12.27
Tandem Diabetes Care Inc stock is traded at $12.27, with a volume of 2.11M.
It is down -4.07% in the last 24 hours and up +10.49% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$12.79
Open:
$12.79
24h Volume:
2.11M
Relative Volume:
1.05
Market Cap:
$829.08M
Revenue:
$796.00M
Net Income/Loss:
$-136.49M
P/E Ratio:
-5.8708
EPS:
-2.09
Net Cash Flow:
$-64.24M
1W Performance:
-2.46%
1M Performance:
+10.49%
6M Performance:
-34.63%
1Y Performance:
-71.96%
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TNDM
Tandem Diabetes Care Inc
|
12.27 | 835.83M | 796.00M | -136.49M | -64.24M | -2.09 |
![]()
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-08-25 | Initiated | Oppenheimer | Outperform |
Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
Jun-16-25 | Initiated | Truist | Hold |
Apr-10-25 | Initiated | Mizuho | Neutral |
Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-06-24 | Initiated | Bernstein | Outperform |
Oct-04-24 | Initiated | Goldman | Neutral |
Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
Aug-08-24 | Initiated | Canaccord Genuity | Buy |
May-30-24 | Initiated | Redburn Atlantic | Buy |
May-22-24 | Upgrade | Citigroup | Neutral → Buy |
Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
Mar-26-24 | Upgrade | Stifel | Hold → Buy |
Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mar-29-23 | Initiated | UBS | Neutral |
Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Oct-18-22 | Initiated | Barclays | Overweight |
Oct-12-22 | Initiated | Jefferies | Buy |
Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
Mar-02-22 | Resumed | BofA Securities | Neutral |
Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jul-21-21 | Resumed | Cowen | Outperform |
May-25-21 | Initiated | Barclays | Underweight |
Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Aug-20-20 | Initiated | Wells Fargo | Overweight |
Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
Jun-18-20 | Reiterated | Raymond James | Outperform |
Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
Mar-05-20 | Initiated | Citigroup | Neutral |
Feb-06-20 | Initiated | Raymond James | Outperform |
Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
Oct-18-19 | Initiated | Guggenheim | Buy |
Oct-04-19 | Upgrade | UBS | Neutral → Buy |
May-17-19 | Reiterated | BofA/Merrill | Neutral |
May-13-19 | Initiated | SVB Leerink | Outperform |
Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
Feb-27-19 | Reiterated | Lake Street | Buy |
Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
Sep-26-18 | Reiterated | Dougherty & Company | Buy |
Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM - Business Wire
Edmond DE Rothschild Holding S.A. Acquires Shares of 252,600 Tandem Diabetes Care, Inc. $TNDM - MarketBeat
What data driven models say about Tandem Diabetes Care Inc.’s future2025 Pullback Review & Free Growth Oriented Trading Recommendations - Newser
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Short Interest in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Decreases By 34.1% - MarketBeat
Levi & Korsinsky Announces an Investigation on Behalf of Tandem Diabetes Care, Inc. (TNDM) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Elliott Wave Theory Predicts Pullback in Tandem Diabetes Care Inc.2025 Market Outlook & Technical Confirmation Trade Alerts - beatles.ru
Sessa Capital IM L.P. Acquires Shares of 4,466,307 Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
RSI Crosses Above 30 for Tandem Diabetes Care Inc. — Reversal in SightJuly 2025 Intraday Action & Risk Adjusted Buy and Sell Alerts - beatles.ru
TNDM's Analyst Ratings: Oppenheimer Lowers Price Target by 50% | - GuruFocus
Oppenheimer Adjusts Tandem Diabetes Care Price Target to $22 From $44, Maintains Outperform Rating - MarketScreener
Oppenheimer maintains Tandem Diabetes Care stock rating, lowers price target - Investing.com Canada
Park West Asset Management LLC Cuts Holdings in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Jacobs Levy Equity Management Inc. Sells 189,444 Shares of Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Take Care Before Jumping Onto Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Even Though It's 27% Cheaper - 富途牛牛
Using Ichimoku Cloud for Tandem Diabetes Care Inc. technicals2025 Volatility Report & Weekly High Return Opportunities - Newser
Should you wait for a breakout in Tandem Diabetes Care Inc.July 2025 Highlights & Consistent Growth Stock Picks - Newser
Is Tandem Diabetes Care Inc. a strong candidate for buy and holdInflation Watch & Free Reliable Trade Execution Plans - خودرو بانک
How does Tandem Diabetes Care Inc. perform in inflationary periodsDay Trade & Safe Swing Trade Setups - خودرو بانک
Long term hold vs stop loss in Tandem Diabetes Care Inc.Fed Meeting & Proven Capital Preservation Methods - Newser
Tandem Diabetes Care shares rise 2.42% premarket after mobile app approval. - AInvest
Analyzing recovery setups for Tandem Diabetes Care Inc. investorsQuarterly Performance Summary & Daily Volume Surge Signals - Newser
Backtesting results for Tandem Diabetes Care Inc. trading strategiesJuly 2025 Institutional & Weekly Top Performers Watchlists - Newser
What to expect from Tandem Diabetes Care Inc. in the next 30 daysWeekly Trade Recap & Fast Gain Swing Alerts - Newser
Technical signs of recovery in Tandem Diabetes Care Inc.July 2025 Action & Momentum Based Trading Ideas - Newser
Tick level data insight on Tandem Diabetes Care Inc. volatilityRisk Management & Stepwise Trade Signal Implementation - Newser
Trend analysis for Tandem Diabetes Care Inc. this weekSell Signal & Expert Approved Trade Ideas - Newser
Tandem Diabetes Care, Inc. Securities Lawsuit Investigation - Claim Depot
What is Tandem Diabetes Care Inc.’s valuation compared to sector2025 Stock Rankings & Precise Swing Trade Alerts - خودرو بانک
Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones - Yahoo Finance
Measuring Tandem Diabetes Care Inc.’s beta against major indicesIndex Update & Weekly Top Stock Performers List - Newser
Applying Wyckoff theory to Tandem Diabetes Care Inc. stockProduct Launch & Stepwise Trade Signal Implementation - Newser
Guidance Update: Is Tandem Diabetes Care Inc. stock a smart retirement pick2025 Dividend Review & Daily Profit Maximizing Tips - خودرو بانک
Price momentum metrics for Tandem Diabetes Care Inc. explainedJuly 2025 Earnings & Weekly Chart Analysis and Guides - Newser
Tandem Diabetes Care Inc. stock retracement – recovery analysisMarket Trend Summary & High Accuracy Swing Trade Signals - Newser
Is now a turning point for Tandem Diabetes Care Inc.Stop Loss & High Conviction Investment Ideas - Newser
What Fibonacci levels say about Tandem Diabetes Care Inc. reboundJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser
Combining price and volume data for Tandem Diabetes Care Inc.Risk Management & Real-Time Chart Breakout Alerts - Newser
How to escape a deep drawdown in Tandem Diabetes Care Inc.2025 Stock Rankings & Long-Term Investment Growth Plans - Newser
How to read the order book for Tandem Diabetes Care Inc.July 2025 Market Mood & Stepwise Swing Trade Plans - Newser
Published on: 2025-09-03 02:48:30 - Newser
How high can Tandem Diabetes Care Inc. stock go2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Sector ETF performance correlation with Tandem Diabetes Care Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - Newser
Why Tandem Diabetes Care Inc. is moving todayInsider Selling & Free Daily Entry Point Trade Alerts - Newser
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):